Although anti-diabetic drugs such as insulin are available to control blood glucose, no significant cardiovascular benefits have been observed in patients treated with insulin (Mamet et al., 2019; Vecchie et al., 2019), and treatment strategies that both reduce hyperglycemia and attenuate cardiac damage are limited. This evidence concerns the gene INS and Hyperglycemia.